Retina

Pic:getty/stockcolors

AffaMed Therapeutics obtains IND clearance for novel retinal biologic

By Rachel Arthur

AffaMed Therapeutics has announced that the US FDA has cleared its Investigational New Drug (IND) application for the clinical development of AM712 (ASKG712), a novel proprietary bispecific biologic molecule blocking both vascular endothelial growth factor...

Pfizer nabs Roslin Cells in cell therapy manufacturing deal

Pfizer nabs Roslin Cells in cell therapy manufacturing deal

By Zachary Brennan

Roslin Cells has signed a contract with Neusentis, a research unit of Pfizer based in Cambridge, UK, to support the manufacture of retinal pigment epithelium (RPE) cells to be used in a cell therapy clinical trial.  

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers